These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8087505)

  • 1. Early stopping rules and long-term follow-up in phase III trials.
    Pignon JP; Arriagada R
    Lung Cancer; 1994 Mar; 10 Suppl 1():S151-9. PubMed ID: 8087505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of futility monitoring guidelines using completed phase III oncology trials.
    Zhang Q; Freidlin B; Korn EL; Halabi S; Mandrekar S; Dignam JJ
    Clin Trials; 2017 Feb; 14(1):48-58. PubMed ID: 27590208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decision-theoretic evaluation of early stopping rules.
    Heitjan DF; Houts PS; Harvey HA
    Stat Med; 1992 Mar; 11(5):673-83. PubMed ID: 1594809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 8. A flexible futility monitoring method with time-varying conditional power boundary.
    Ying Zhang ; Clarke WR
    Clin Trials; 2010 Jun; 7(3):209-18. PubMed ID: 20423927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical problems in interim analyses, with particular regard to estimation.
    Pocock SJ; Hughes MD
    Control Clin Trials; 1989 Dec; 10(4 Suppl):209S-221S. PubMed ID: 2605969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ethics of early stopping rules.
    Pater J; Goss P; Ingle J; Shelley W; Shepherd L
    J Clin Oncol; 2005 Apr; 23(12):2862-3; author reply 2863-4. PubMed ID: 15838002
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of antibacterial agents: a practical guide to design and analysis. Statisticians in the Pharmaceutical Industry Working Party.
    Smith C; Burley C; Ireson M; Johnson T; Jordan D; Knight S; Mason T; Massey D; Moss J; Williams K
    J Antimicrob Chemother; 1998 Apr; 41(4):467-80. PubMed ID: 9598778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible implementations of group sequential stopping rules using constrained boundaries.
    Burington BE; Emerson SS
    Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.
    Mistry P; Dunn JA; Marshall A
    BMC Med Res Methodol; 2017 Jul; 17(1):108. PubMed ID: 28720094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interim analyses].
    Kramar A; Paoletti X
    Bull Cancer; 2007 Nov; 94(11):965-74. PubMed ID: 18055314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ethics of early stopping rules: who is protecting whom?
    Cannistra SA
    J Clin Oncol; 2004 May; 22(9):1542-5. PubMed ID: 15117977
    [No Abstract]   [Full Text] [Related]  

  • 18. Information time scales for interim analyses of randomized clinical trials.
    Freidlin B; Othus M; Korn EL
    Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods.
    Hulot JS; Cucherat M; Charlesworth A; Van Veldhuisen DJ; Corvol JC; Mallet A; Boissel JP; Hampton J; Lechat P
    Br J Clin Pharmacol; 2003 Mar; 55(3):299-306. PubMed ID: 12630981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of International Trials Working Group.
    Nzila N
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1423-5. PubMed ID: 1466972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.